The purpose of the program with CerviCusco is to demonstrate the feasibility and acceptance of human papillomavirus (HPV) vaccination in the hard-to-reach-populations of rural Cusco, Peru. In 2016, Merck made a donation of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] which is expected to allow vaccination coverage of 30,000 individuals. The vaccine is administered free of charge at CerviCusco’s clinic in Larapa, Cusco, and through mobile clinics to reach young people who would otherwise not have access.
Vaccination campaign. Cervi Cusco Primary and Secondary Prevention. http://cervicusco.org/en/whatwedo/prevention/ (Accessed December 12, 2017).
for more information